Hamrick Investment Counsel’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Hamrick Investment Counsel's BMY Position: Q2 2026 in Review
Hamrick Investment Counsel reduced its Bristol-Myers Squibb (BMY) stake by 97% in Q2 2026, selling an estimated $230K and leaving 135 shares worth $7.78K. The position accounts for 0.01% of the portfolio, ranked #144.
Hamrick Investment Counsel first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $251K in Q1 2026. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Hamrick Investment Counsel held 135 shares of Bristol-Myers Squibb worth $7.78K as of Q2 2026.
- Hamrick Investment Counsel sold 4,006 Bristol-Myers Squibb shares in Q2 2026, an estimated $230K.
- Bristol-Myers Squibb made up 0.01% of Hamrick Investment Counsel's portfolio in Q2 2026, its #144 holding.
- Hamrick Investment Counsel first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- Hamrick Investment Counsel's Bristol-Myers Squibb position peaked at $251K in Q1 2026.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Hamrick Investment Counsel's 13F filing for Q2 2026, filed 13 Aug 2026.